Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Fenibut gav abstinens och psykos. Preparat för kosmonauter - nu marknadsfört som kosttillskott på nätet
Engelsk titel: Phenibut yielded withdrawal symptoms and psychosis. Drugs for cosmonauts - now marketed as dietary supplements online Läs online Författare: Högberg, Lovisa ; Szabo, Istvan ; Ruusa, Jaan Språk: Swe Antal referenser: 19 Dokumenttyp: Fallbeskrivning UI-nummer: 13067417

Tidskrift

Läkartidningen 2013;110(16)825-7 ISSN 0023-7205 E-ISSN 1652-7518 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

In this article we compare and discuss three previously published cases of phenibut withdrawal. Phenibut is a GABAB agonist that was developed in Soviet in the 1960’s. In Russia it is used in clinical practice to treat, for example, anxiety and alcohol withdrawal syndrome. In Europe and in USA phenibut is available on the Internet and marketed as a nutritional supplement for improved sleep. The case reports describe a rapid tolerance development and potentially severe withdrawal symptoms, similar to those seen in baclofen, GHB, benzodiazepine and alcohol withdrawal. Symptoms range from subjective experiences of stress, anxiety, low self-esteem and palpitations to objective symptoms such as tremor, agitation, hallucinations and confusion. Benzodiazepines and supportive care seems to be the most effective choice of treatment for objective abstinence symptoms.